Welcome! Thank you for subscribing to the Earnings360 newsletter, your daily source for quarterly earnings news and updates.
Each morning edition contains a wrap-up of today's pre-market earnings announcements and yesterday's earnings announcements after the closing bell.
Please take a moment to confirm your subscription below so we can ensure these updates reach your inbox.
Confirm Your Subscription Here
The Earnings360 Team
Additional Reading from MarketBeat.com 3 Up-and-Coming Stocks Showing Huge Momentum in Late 2025Written by Chris Markoch. Published 12/2/2025. Many investors have profited from the artificial intelligence (AI) trade in 2025. But there have been several up-and-coming stocks in other sectors that have posted impressive gains this year. The three stocks profiled here are still small — the largest has a market cap just over $4 billion — but they've delivered strong moves, illustrating that time in the market often beats trying to time it. That said, if investors could see the future with absolute clarity, investing would be easy. Unfortunately, the future is rarely clear, and a bullish outcome is not inevitable. Still, the charts speak for themselves. Investors who bought these names and had the patience to hold through rough patches are reaping the benefits today — and the stocks may not be done moving higher. Biotech Breakthrough: A Small Cap With a Big 2026 FDA Catalyst Some of Wall Street's biggest players have been taking advantage of the same early-morning price behavior for years — a pattern that appears shortly after the opening bell when overnight institutional flows hit the market. Most retail traders never notice it, but Dave Aquino has spent years studying this window and developed a simple routine built to capitalize on it without relying on news or predictions.
He calls it the Good Morning Cash Plan — a single morning setup designed to give traders a structured, rules-based approach before the day even begins. Dave breaks down the full method in a free training session, including how he identifies the setup each morning. Watch the Good Morning Cash Plan training here Key Points - These three up-and-coming stocks have delivered triple-digit gains in 2025 and continue to show strong momentum.
- Key catalysts—including clinical milestones, revenue acceleration, and consumer demand—suggest more upside ahead.
- Analysts remain bullish, with price targets indicating potential double-digit to triple-digit returns from current levels.
Celcuity Inc. (NASDAQ: CELC) is a clinical-stage biotechnology company that recently delivered positive data for its first-in-class PI3K/mTOR inhibitor targeting HR+/HER2‑ metastatic breast cancer. The company's pivotal Phase 3 VIKTORIA trial is underway, and some investors believe Celcuity could receive U.S. Food & Drug Administration (FDA) approval in 2026. Investors have been front-running those results, pushing CELC stock up more than 660%, with almost all of those gains occurring since the end of July. At $99.30 as of this writing, the stock sits within about 3% of its consensus price target. Meanwhile, Jefferies raised its price target on December 2 to $134 from $108. The biggest risk for investors is the financial burden of commercialization. In its most recent earnings report, Celcuity reported a strengthened balance sheet with $455 million in cash, cash equivalents and short-term investments — up about 72% year-over-year (YoY). Management says that should be sufficient until commercialization begins. Fintech Disruptor Turning Revenue Growth Into Real Momentum At a time when traditional banks have less to offer many consumers, it's easy to make the case for Dave Inc. (NASDAQ: DAVE), the Los Angeles-based fintech behind the Dave app. The Dave app provides affordable, transparent financial tools that help users — many of whom live paycheck to paycheck — avoid overdraft fees, budget more effectively and access short-term cash when needed. The company recently reported a 64% YoY increase in revenue and an 85% beat in adjusted earnings per share (EPS). DAVE stock is up about 120% in 2025, and analysts see further upside. As of this writing, the stock was trading at $208.24, with a consensus price target of $304.25 — roughly 46% higher. Some investors may worry about the company's forward price-to-earnings (P/E) ratio of around 119x. However, analysts forecast earnings growth of more than 117% over the next 12 months, and that pace of growth could help justify the current valuation. Resale Retail Winner Riding a Massive Consumer Shift It's been another tough year for consumer staples stocks, but ThredUp Inc. (NASDAQ: TDUP) has been a notable exception. TDUP stock is up more than 430% in 2025, despite a roughly 29% sell-off in the three months ending December 1. The company operates an online consignment marketplace, a good fit as many consumer budgets remain stretched. The thrift and resale market was a $49 billion industry in 2024 and is expected to grow to $74 billion by 2029. TDUP is the smallest of the three names here, and short interest north of 17% indicates active trading. That said, the company's Q3 report showed strong YoY revenue growth and, notably, a record increase in new buyer acquisition along with a 37% YoY rise in orders. Admittedly, this could be a shorter-term trade. But the younger consumers that make up ThredUp's core market will probably feel financially squeezed for some time, which helps explain why analysts give TDUP a consensus price target of $12.50 — about 68% above its closing price on December 1.
| 
